CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Idera Pharmaceuticals, Inc.  (IDRA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
 

IDRA's Revenue Year on Year Growth by Quarter and Year

Idera Pharmaceuticals,'s Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
IDRA Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 15.28 0.19 -
III Quarter September - 0.32 0.02 0.03
II Quarter June - 0.30 0.01 0.04
I Quarter March 0.38 0.29 0.03 -
FY   0.38 16.19 0.25 0.07

Financial Statements
Idera Pharmaceuticals,'s first quarter 2017 Revenue $ 0.38 millions IDRA's Income Statement
Idera Pharmaceuticals,'s first quarter 2016 Revenue $ 0.29 millions Quarterly IDRA's Income Statement
IDRA's Growth by Division See IDRA's Growth by Segment

IDRA Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - 7942.11 % - -
III Quarter September - 1500 % -33.33 % 200 %
II Quarter June - 2900 % -75 % 33.33 %
I Quarter March 30.34 % 866.67 % - -
FY   - 6376 % 257.14 % -



IDRA Revenue Growth Comment
Idera Pharmaceuticals, Inc. reported Revenue improvement of 30.34% year on year in the first quarter, to $ 0.38 millions, this is lower than Idera Pharmaceuticals, Inc.'s recent average Revenue surge of 1575.74%.

Looking into first quarter results within Biotechnology & Drugs industry 29 other companies have achieved higher Revenue growth. While Idera Pharmaceuticals, Inc.' s Revenue rise of 30.34% ranks overall at the positon no. 766 in the first quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #30
Healthcare Sector #119
S&P 500 #766
Revenue Y/Y Growth Statistics
High Average Low
9400 % 1575.74 % -86.84 %
(Dec 31 2015)   (Jun 30 2015)

You need to upgrade your Flash Player

Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
IDRA's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for IDRA's Competitors
Revenue Growth for Idera Pharmaceuticals,'s Suppliers
Revenue Growth for IDRA's Customers

You may also want to know
IDRA's Annual Growth Rates IDRA's Profitability Ratios IDRA's Asset Turnover Ratio IDRA's Dividend Growth
IDRA's Roe IDRA's Valuation Ratios IDRA's Financial Strength Ratios IDRA's Dividend Payout Ratio
IDRA's Roa IDRA's Inventory Turnover Ratio IDRA's Growth Rates IDRA's Dividend Comparisons



Companies with similar Revenue rise for the quarter ending Mar 31 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2017
Axogen, Inc.  50.91 %$ 50.905 millions
Organovo Holdings, Inc.  48.18 %$ 48.175 millions
Wound Management Technologies, Inc.  46.57 %$ 46.568 millions
Lexicon Pharmaceuticals, Inc.  46.41 %$ 46.414 millions
Incyte Corp  45.78 %$ 45.782 millions
Stemline Therapeutics Inc  45.59 %$ 45.587 millions
Immunogen Inc  44.56 %$ 44.562 millions
Diversicare Healthcare Services, Inc.  44.47 %$ 44.469 millions
Natus Medical Inc  42.75 %$ 42.748 millions
Invuity, Inc.  40.90 %$ 40.896 millions
Ptc Therapeutics, Inc.  40.50 %$ 40.497 millions
Select Medical Holdings Corp  39.73 %$ 39.734 millions
Imprimis Pharmaceuticals, Inc.  39.17 %$ 39.169 millions
Bellicum Pharmaceuticals, Inc.  39.13 %$ 39.130 millions
Semler Scientific, Inc.  36.91 %$ 36.909 millions
Mimedx Group, Inc.  36.05 %$ 36.052 millions
Amarin Corp Plcuk  35.60 %$ 35.603 millions
Novavax Inc  34.66 %$ 34.661 millions
Momenta Pharmaceuticals Inc  34.08 %$ 34.076 millions
Aytu Bioscience, Inc  33.66 %$ 33.656 millions
Nobilis Health Corp.  33.21 %$ 33.212 millions
Axim Biotechnologies, Inc.  32.95 %$ 32.953 millions
Abiomed Inc  32.70 %$ 32.699 millions
Misonix Inc  32.28 %$ 32.281 millions
Cutera Inc  30.66 %$ 30.665 millions
Synergy Chc Corp.  30.49 %$ 30.487 millions
Supernus Pharmaceuticals Inc  30.28 %$ 30.280 millions
Pacific Biosciences Of California, Inc.  30.26 %$ 30.261 millions
Align Technology Inc  30.00 %$ 30.002 millions
Abbott Laboratories  29.68 %$ 29.683 millions


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com